Deep Track Capital LP 13D and 13G filings for RAPT Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-12-23 4:42 pm Purchase | 2024-12-23 | 13G | RAPT Therapeutics, Inc. RAPT | Deep Track Capital LP | 14,116,000 9.870% | 14,116,000 (New Position) | Filing |
2024-11-14 09:39 am Sale | 2024-09-30 | 13G | RAPT Therapeutics, Inc. RAPT | Deep Track Capital LP | 0 0.000% | -1,793,966 (Position Closed) | Filing |
2024-02-14 08:52 am Sale | 2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Deep Track Capital LP | 1,793,966 5.220% | -197,437 (-9.91%) | Filing |
2023-10-23 4:40 pm Purchase | 2023-10-13 | 13G | RAPT Therapeutics, Inc. RAPT | Deep Track Capital LP | 1,991,403 5.800% | 1,991,403 (New Position) | Filing |